Operational Considerations: Workflow Adjustments and Monitoring Systems for Effective COCOON Implementation

EP: 1.Clinical Insights: Experiences With Amivantamab-Lazertinib in EGFR-Mutant NSCLC

EP: 2.Overview of Study Design of the COCOON Trial

EP: 3.COCOON Baseline Characteristics

EP: 4.COCOON: Discussion of Clinical End Points and Dose Modifications

EP: 5.Initial Reactions to COCOON Study’s Dermatologic/Nail AE Reductions

EP: 6.Clinician Experiences: COCOON Regimen vs Traditional SoC AE Management

EP: 7.Measuring Impact: Observed Differences in Dermatologic AEs Between COCOON Protocol and Standard Approaches

EP: 8.Building Support Systems: Resources and Multidisciplinary Collaboration for Optimizing COCOON Implementation

Now Viewing

EP: 9.Operational Considerations: Workflow Adjustments and Monitoring Systems for Effective COCOON Implementation

EP: 10.COCOON in Practice: Patient Preparation, Key Insights, and Implementation Best Practices

Video content above is prompted by the following:

COCOON Protocol Implementation Discussion

Overview

This summary captures a discussion about the implementation of the COCOON protocol for patients, focusing on logistical considerations, patient education materials, and clinical feedback.

Key Points

Logistical Implementation

• A built-in order set has been integrated into the electronic medical record (EMR) system.
• The EMR integration serves as an important reminder for deep vein thrombosis (DVT) prophylaxis.
• While implementing COCOON protocol, providers are ensuring DVT prophylaxis is not overlooked

Patient Education Materials

• Printed handouts are being provided to patients along with electronic information.
• Paper materials serve as valuable visual references that patients can easily access later.
• This dual approach accommodates varying technology comfort levels across different age groups.
• The speaker notes that many patients are not completely “tech savvy” and appreciate having physical handouts.

Patient Response

• Randi Rabin reports no negative feedback from patients regarding the protocol.
• Patients are generally enthusiastic about receiving proactive guidance.
• Patients appreciate being empowered with knowledge about preventing and treating adverse effects.
• There has been no pushback from patients on implementing these measures.

Patient Motivation

• Patients are motivated to stay on their medications.
• Randi Rabin emphasized that patients want to live “as full and meaningful a life as you and me.”
• Patients are receptive to interventions that help them maintain their treatment regimens.

Conclusion

The implementation of the COCOON protocol appears to be proceeding smoothly with positive reception from patients. The combination of EMR integration and physical handouts provides comprehensive support, accommodating diverse patient preferences and ensuring essential care components are not overlooked.